血源筛查乙型肝炎病毒的新策略  

New Strategy of Blood Screening for Hepatitis B Virus

作　　者：白玉[1] 常卫红[1] 

机构地区：[1]国家食品药品监督管理局药品审评中心生物制品室,北京100038

出　　处：《中国生物制品学杂志》2010年第8期906-909,共4页Chinese Journal of Biologicals

摘　　要：我国是乙型肝炎病毒(HBV)感染高流行地区,由HBV引起的输血相关肝炎的预防和控制日益受到关注,而新的检测技术(如核酸检测)的引入是降低HBV感染风险、提高血源安全的重要措施之一。本文对HBV核酸检测在血源筛查中的应用现状作一综述,并探讨我国HBV血源筛查的策略。There is a high prevalence of hepatitis B virus （HBV）in China where the prevention and control of transfusiontransmitted hepatitis B has been paid more and more attention. The introduction of novel techniques, such as nucleic acid testing （NAT）, is one of the important measures to decrease the risk of HBV infection and increase the blood safety. In this paper, the status of application of NAT for HBV in blood screening is reviewed, and the strategy of blood screening for HBV is investigated.

关 键 词：血源筛查 核酸检测 肝炎病毒 乙型 策略 

分 类 号：R373.2[医药卫生—病原生物学]